Meena Rajarethinam

Meena Rajarethinam

Auto-generated profile, based on publicly available information

Meena Rajarethinam

Central Council for Research in Siddha, Chennai, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
PPP. Prakash
P. Prakash
RMR. Meena
R. Meena
LAL. Stanley Abraham
L. Stanley Abraham
SSSwetha Sunkar
Swetha Sunkar
KGK. Govindaraju
K. Govindaraju
ASAntony V. Samrot
Antony V. Samrot

1 April 2021 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
RMR. Meena
R. Meena
SNS. Natarajan
S. Natarajan
CAC. Anbarasi
C. Anbarasi
PSP. Sathiyarajeswaran
P. Sathiyarajeswaran
A 60 year married female from Chennai presented with pain and restricted abduction, adduction, external rotation and flexion of right shoulder both in active and passive movements for 2 months. She was diagnosed to be affected by adhesive capsulitis which is equated to Kumbavatham, one of the vatha diseases mentioned in Siddha system of medicine. She was treated with Siddha Varmam therapy and thokkanam with Vathakesari thylam. After 15 days of hospital stay the patient was discharged and was followed for 6 months. There were no adverse reactions/events observed during the course of treatment. The combination therapy has provided the reduction in pain and restricted movements which was measured using goniometer and SPADI index.

20 January 2026 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
AAAZEEM AHMAD
AZEEM AHMAD
MGManohar S. Gundeti
Manohar S. Gundeti
MRMeena R
Meena R
EWEugene Wilson
Eugene Wilson
MIMalik Itrat
Malik Itrat
GRGalib R
Galib R
The novel coronavirus (COVID-19), caused by SARS-CoV-2, was first reported in Wuhan, China, in December 2019. Its rapid spread, high mutation rate, and cha

29 April 2023 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
MRMeena R
Meena R
KGKiruthiga G
Kiruthiga G
PPPrakash P
Prakash P
Siddha medicine is an ancient Indian medical system originated in South India. The holistic approach of the Siddha system finds cure for many ailments and also guides to a perfect living right from conception to death. The ‘S’ in the acronym AYUSH represents Siddha. The Siddha multiherbal formulation Mahathuthulathi chooranam, found in the classical text book Koshayi Anuboga Vaithiya Bramma Ragasiyam - part 2, is indicated for Aiyam (Phlegm) predominant diseases. The review seeks to establish the documented literature on the therapeutic efficacy of the Mahathuthulai chooranam in respiratory illness through a critical review. It was carried out by searching Siddha classic texts from the library of Siddha Central Research Institute, electronic search engines, databases such as Google scholar, Pub Med Central, NLM, Mendeley, Embase, Science Direct etc. The results of the review suggest that the drug can be a part of the comprehensive treatment of adverse respiratory illnesses in addition to prevention of complications in vulnerable risk patients. The drug is substantiated to be a safe and efficacious drug in treating acute respiratory illnesses through supporting evidences. A robust clinical trial is essential to evaluate the clinical outcomes to prove the drug’s efficiency.

27 December 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
GRGalib R
Galib R
AAAZEEM AHMAD
AZEEM AHMAD
MGManohar S. Gundeti
Manohar S. Gundeti
MRMeena R
Meena R
EWEugene Wilson
Eugene Wilson
SPShifa Shetty P
Shifa Shetty P
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Introduction: Non-communicable diseases, particularly Diabetes, are a growing global burden, with India rapidly becoming the diabetes capital of the world. Data on diabetes Awareness, treatment, and control from 20,78,315 Indians in NFHS-5 in 2023 revealed that of those with the disease, 27.5% (27.1–27.9%) were aware, 21.5% (21.1–21.7%) were receiving treatment, and only 7% (6.8–7.1%) had their diabetes under control. Over 81% of people with diabetes hail from low-and middle-income countries. With their emphasis on lifestyle management and holistic approach, traditional medical systems present a promising alternative that may help lessen the burden of diabetes through sustainable and natural methods. Traditional medicine uses many therapeutic concepts to manage diabetes, but there is no appropriate methodology to demonstrate their effectiveness. Objective: The aim of this study is to develop a protocol that qualitatively evaluates the status of evidence on safety and efficacy of Indian Traditional systems of Medicine (AYUSH) for the management of Pre-diabetes and Type- II Diabetes Mellitus to establish a road map of evidence through research for better outcomes in future. Methods: All study designs including Systematic reviews and meta-analysis, Narrative reviews, RCTs, non-randomized CTs , parallel arm intervention trials, Pre-test post-test trials, observational studies (including cross-sectional , case- control and cohort studies), case series and case reports from the first available published literature to July 2024 will be assessed. All the AYUSH interventions studied in India as Standalone or Add-on to Standard of Care for the management of Diabetes will be included in the study. The database search will be performed with all AYUSH key words related to Prediabetes and Type II Diabetes mellitus using Boolean operators. The safety and efficacy of AYUSH interventions will be evaluated based on specified Subjective and objective measures including Clinical recovery, Quality of Life, any adverse events that are specific or otherwise based on LFT, KFT, and Lipid profile etc. Results: A preliminary scoping of the literature indicates a diverse range of AYUSH interventions for diabetes management, with varying levels of evidence on safety and efficacy. Initial findings highlight gaps in well-designed clinical studies and standardized outcome measures, emphasizing the need for systematic evaluation. Conclusions: Large translational gaps remain despite increased awareness of the global diabetes crisis and ongoing multinational efforts to curb rising diabetes rates which makes way for the contribution of Traditional system of medicine. Though there are differences in treatment types available in India's traditional medicine systems, a protocol has been developed to effectively map the evidence for all treatments available for Type II diabetes and prediabetes in AYUSH systems of medicine. Clinical Trial: PROSPERO (International Prospective Register for Systematic Reviews) Reg. No. – CRD42024545045

27 December 2024 in JMIR Preprints
Verified
Preprint
Open access
GRGalib R
Galib R
AAAZEEM AHMAD
AZEEM AHMAD
MGManohar S. Gundeti
Manohar S. Gundeti
MRMeena R
Meena R
EWEugene Wilson
Eugene Wilson
SPShifa Shetty P
Shifa Shetty P
BACKGROUND Introduction: Non-communicable diseases, particularly Diabetes, are a growing global burden, with India rapidly becoming the diabetes capital of the world. Data on diabetes Awareness, treatment, and control from 20,78,315 Indians in NFHS-5 in 2023 revealed that of those with the disease, 27.5% (27.1–27.9%) were aware, 21.5% (21.1–21.7%) were receiving treatment, and only 7% (6.8–7.1%) had their diabetes under control. Over 81% of people with diabetes hail from low-and middle-income countries. With their emphasis on lifestyle management and holistic approach, traditional medical systems present a promising alternative that may help lessen the burden of diabetes through sustainable and natural methods. Traditional medicine uses many therapeutic concepts to manage diabetes, but there is no appropriate methodology to demonstrate their effectiveness. OBJECTIVE The aim of this study is to develop a protocol that qualitatively evaluates the status of evidence on safety and efficacy of Indian Traditional systems of Medicine (AYUSH) for the management of Pre-diabetes and Type- II Diabetes Mellitus to establish a road map of evidence through research for better outcomes in future. METHODS All study designs including Systematic reviews and meta-analysis, Narrative reviews, RCTs, non-randomized CTs , parallel arm intervention trials, Pre-test post-test trials, observational studies (including cross-sectional , case- control and cohort studies), case series and case reports from the first available published literature to July 2024 will be assessed. All the AYUSH interventions studied in India as Standalone or Add-on to Standard of Care for the management of Diabetes will be included in the study. The database search will be performed with all AYUSH key words related to Prediabetes and Type II Diabetes mellitus using Boolean operators. The safety and efficacy of AYUSH interventions will be evaluated based on specified Subjective and objective measures including Clinical recovery, Quality of Life, any adverse events that are specific or otherwise based on LFT, KFT, and Lipid profile etc. RESULTS protocol is developed. CONCLUSIONS Large translational gaps remain despite increased awareness of the global diabetes crisis and ongoing multinational efforts to curb rising diabetes rates which makes way for the contribution of Traditional system of medicine. Though there are differences in treatment types available in India's traditional medicine systems, a protocol has been developed to effectively map the evidence for all treatments available for Type II diabetes and prediabetes in AYUSH systems of medicine. CLINICALTRIAL PROSPERO (International Prospective Register for Systematic Reviews) Reg. No. – CRD42024545045